Clinical Stage Partnering Terms and Agreements in Pharma and Biotech: 1,775 Deals + SEC Contracts, Top 25 Dealmaker Profiles, 2020-2025 [Yahoo! Finance]
Whitehawk Therapeutics, Inc. (WHWK)
Company Research
Source: Yahoo! Finance
royalty ranges, plus links to deal records and SEC-filed contracts where available. Content spans why companies partner, common structures (licensing, options, co-dev/commercialization), payment triggers, and trends by year, phase, therapy area, technology, and dealmaker. Includes case studies, the top 25 most active partners, and the highest-value deals to help teams benchmark terms and sharpen negotiation strategy. Dublin, Oct. 13, 2025 (GLOBE NEWSWIRE) -- The "Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025" report has been added to ResearchAndMarkets.com's offering. The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides a comprehensive, data-driven analysis of how and why companies engage in clinical-stage partnering agreements, as well as the financial and strategic terms shaping these collaborations. This essential industry resource delivers unparalleled insights into deal structures, negotiation dynamics, and
Show less
Read more
Impact Snapshot
Event Time:
WHWK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WHWK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WHWK alerts
High impacting Whitehawk Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
WHWK
News
- Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical OfficerPR Newswire
- Whitehawk Therapeutics (NASDAQ:WHWK) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare ConferencePR Newswire